Epilepsy Research
Volume 22, Issue 1 , Pages 53-62 , September 1995

Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve

  • Dean K. Naritoku

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Neurology, Southern Illinois University School of Medicine, P.O. Box 19230, Springfield, IL 62794-9230, USA. Tel.: (217) 785-5175; fax: (217) 524-4539.
    • Department of Neurology, Southern Illinois University School of Medicine, Springfield, IL 62794-9230, USA
    • Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL 62794-9230, USA
    • ,
  • Wendy J. Terry

      Affiliations

    • Department of Neurology, Southern Illinois University School of Medicine, Springfield, IL 62794-9230, USA
    • ,
  • Robert H. Helfert

      Affiliations

    • Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL 62794-9230, USA
    • Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL 62794-9230, USA

Received 22 November 1994 ,Accepted 30 May 1995.

References 

  1. Aghajanian GK, Wang RY. Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res. 1977;122:229–242
  2. Ambalavanar R, Van der Zee EA, Bolhuis JJ, McCabe BJ, Horn G. Co-expression of Fos immunoreactivity in protein kinase (PKCgamma)-positive neurones: Quantitative analysis of a brain region involved in learning. Brain Res. 1993;606:315–318
  3. Ben-Menachem E, Mañion-Espillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, et al. Vagus nerve stimulation for treatment of partial seizures. I. A controlled study of effect on seizures. Epilepsia. 1994;35:515–626
  4. Bing G, Stone EA, Zhang Y, Filer D. Immunohistochemical studies of noradrenergic-induced expression of c-fos in the rat CNS. Brain Res. 1992;592:57–62
  5. Burchfiel JL, Applegate CD. Stepwise progression of kindling: Perspective from the kindling antagonism model. Neurosci. Behav. Rev. 1989;13:289–299
  6. Chase MH, Nakamura Y, Clemente CD, Sternman MB. Afferent vagal stimulation: Neurographic correlates of induced EEG synchronization and desynchronization. Brain Res. 1967;5:236–249
  7. Daval J-L, Nakajima T, Gleiter CH, Post RM, Marangos PJ. Mouse brain c-fos mRNA distribution following a single electroconvulsive shock. J. Neurochem. 1989;52:1954–1957
  8. DeSarro G, Meldrum BS, DeSarro A, Patel S. Excitatory neurotransmitters in the lateral habenula and pedunculopontine nucleus of rat modulate limbic seizures induced by pilocarpine. Brain Res. 1992;591:209–222
  9. DeTogni P, Niman H, Raymaond V, Sawchenko P, Verma IM. Detection of fos protein during osteogenesis by monoclonal antibodies. Mol. Cell Biol. 1988;8:2251–2256
  10. Ding JM, Carver WC, Terrachio L, Buggy J. Proto-oncogene c-fos and the regulation of vasopressin gene expression during dehydration. Mol. Brain Res. 1994;21:247–255
  11. Distel RJ, Spiegelman B. Protooncogene c-fos as a transcription factor. In: 2nd ed..  VandeWoude GF,  Klein G editor. Advances in Cancer Research. Vol. 55:San Diego: Academic Press; 1990;p. 37–55
  12. Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods. 1989;29:261–265
  13. Faingold CL, Riaz A. Neuronal networks in convulsant drug-induced seizures. In:  Faingold CL,  Fromm GH editor. Drugs for the Control of Epilepsy. Boca Raton: CRC Press; 1992;p. 213–251
  14. Fromm GH, Sun K. How does vagal nerve stimulation prevent seizures?. Epilepsia. 1993;34(S6):52
  15. Garant DS, Xu SG, Sperber EF, Moshe SL. The influence of thalamic GABA transmission on the susceptibility of adult rats to flurothyl induced seizures. Epilepsy Res. 1993;15:185–192
  16. Gellman RL, Aghajanian GK. Pyramidal cells in pyriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 1993;600:600–673
  17. Gellman RL, Kallianos JA, McNamara JO. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development. J. Pharmacol. Exp. Ther. 1987;241:891–898
  18. George R, Salinsky M, Kuzniecky R, Rosenfeld W, Bergen D, Tarver WB, et al. Vagus nerve stimulation for treatment of partial seizures. 3. Long-term follow-up on first 67 patients exiting a controlled study. Epilepsia. 1994;35:637–643
  19. Goldman MS, Kelly PJ. Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor. J. Neurosurg. 1992;77:223–229
  20. Gowers, W.R., Epilepsy and Other Chronic Convulsive Diseases, J. and A. Churchill, London, pp. 93–97.
  21. Hammond EJ, Uthman BM, Reid SA, Wilder BJ. Electrophysiological studies of cervical vagus nerve stimulation in humans. I. EEG effects. Epilepsia. 1992;33:1013–1020
  22. Hammond EJ, Uthman BM, Wilder BJ, BenMenachem E, Hamberger A, Hedner T, et al. Neurochemical effects of vagus nerve stimulation in humans. Brain Res. 1992;583:300–303
  23. Handforth A, Ackermann RF. Electrically induced limbic status and kindled seizures. In:  Meldrum BS,  Ferrendelli JA,  Wieser HG editor. Current Problems in Epilepsy: Anatomy of Epileptogenesis. London: John Libbey; 1988;
  24. Hauser WA, Hessdorfer DC. Epilepsy: Frequency, Causes and Consequences. In: New York: Demos; 1990;p. 224
  25. Herrera DG, Robertson HA. N-methyl-d-aspartate receptors mediate activation of the c-fos proto-oncogene in a model of brain injury. Neuroscience. 1990;35:273–281
  26. Hughes P, Dragunow M. Muscarinic receptor-mediated induction of Fos protein in rat brain. Neurosci. Lett. 1993;150:122–126
  27. Hsu S-M, Raine L, Fanger H. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981;29:577–580
  28. Iadarola MJ, Gale K. Substantia nigra: Site of anticonvulsant activity mediated by gamma-amino butyric acid. Science. 1982;218:1237–1240
  29. Jobe PC, Mishra PK, Dailey JW. Genetically epilepsy-prone rats: Actions of antiepileptic drugs and monoaminergic neurotransmitters. In:  Faingold CL,  Fromm GH editor. Drugs for the Control of Epilepsy. Boca Raton: CRC Press; 1992;p. 253–275
  30. Katz A, Awad IA, Kong AK, Chelune GJ, Naugle RI, Wylle E, et al. Extent of resection in temporal lobectomy for epilepsy. II. Memory changes and neurologic complications. Epilepsia. 1989;30:763–771
  31. Krahl SE, Browning RA, Smith DC. Possible mechanism of the seizure attenuating effects of vagus nerve stimulation. Soc. Neurosci. Abstr. 1994;20:1453
  32. Labiner DM, Butler LS, Cao Z, Hosford DA, Shin C, McNamara JO. Induction of c-fos mRNA by kindled seizures: Complex relationship with neuronal burst firing. J. Neurosci. 1993;13:744–751
  33. Levitt P, Lau C, Pylypiw A, Ross LL. Central adrenergic receptor changes in the inherited noradrenergic hyperinnervated mutant mouse tottering. Brain Res. 1987;418:174–177
  34. Lockard JS, Congdon WC, DuCharme LL. Feasibility and safety of vagal stimulation in monkey model. Epilepsia. 1990;31(S2):S20–S26
  35. Maixner W. Vagal modulation of nociception: A critique. APS J. 1992;1:33–35
  36. Mañon-Espaillat R, Wernicke JF. Relationship between antiepileptic effect of vagus nerve stimulation and interictal epileptiform discharges. Epilepsia. 1994;35(S7):40
  37. McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia. 1993;34:918–923
  38. Miller JW, Ferrendelli JA. Characterization of GABAergic seizure regulation in the midline thalamus. Neuropharmacology. 1990;29:649–655
  39. Mondragon S, Lamarche M. Suppression of motor seizures after specific thalamotomy in chronic epileptic monkeys. Epilepsy Res. 1990;5:137–145
  40. Morgan JI, Cohen DR, Hempstead JL, Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 1987;237:192–197
  41. Murphy TH, Worley PF, Baraban JM. L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes. Neuron. 1991;7:625–635
  42. Naritoku DK, Morales A, Pencek TL, Winkler D. Chronic vagus nerve stimulation increases the latency of the thalamocortical somatosensory evoked potential. Pacing Clin. Electrophysiol. 1992;15(II):1572–1578
  43. Naritoku DK, Terry WJ, Helfert RH. Intermittent vagus nerve stimulation (VNS) activates brainstem noradrenergic nuclei. Epilepsia. 1994;35(S7):3
  44. Noebels JA, Rutecki PA. Altered hippocampal network excitability in the hypernoradrenergic mutant mouse tottering. Brain Res. 1990;524:225–230
  45. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed.. Orlando: Academic Press; 1986;
  46. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: Preliminary results. Epilepsia. 1990;31(S2):S40–S43
  47. Pezzone MA, Lee W-S, Hoffman GE, Rabin BS. Induction of c-fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli. Brain Res. 1992;597:41–51
  48. Ramsay RE, Uthman BM, Augustinsson E, Upton ARM, Naritoku D, Willis J, et al. Vagus nerve stimulation for treatment of partial seizures. 2. Safety, side effects, and tolerability. Epilepsia. 1994;35:527–636
  49. Ricardo JA, Koh ET. Anatomic evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 1978;153:1–26
  50. Ristanovic RK, Bergen D, Smith M, Tarver WB, Wernicke JF. Vagus nerve stimulation: Seizure rate evolution after generator end-of-service and following replacement of the generator. Epilepsia. 1994;35(S7):40; (abstract)
  51. Rutecki P. Anatomical, physiological and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990;31(S2):S1–S6
  52. Rutherford SD, Widdopp RE, Sannajust F, Louis WJ, Gundlach AL. Expression of c-fos and NGFI-A messenger RNA in medulla oblongata of the anaesthetized rat following stimulation of vagal and cardiovascular afferents. Mol. Brain Res. 1992;13:301–312
  53. Salinsky MC, Burchiel KJ. Vagus nerve stimulation has no effect on awake EEG rhythms in humans. Epilepsia. 1993;34:299–304
  54. Saper CB, Loewy AD. Efferent connections of the parabrachial nucleus in the rat. Brain Res. 1980;197:291–317
  55. Sass KJ, Spencer D, Spencer SS, Novelly RA, Williamson PD, Mattson RH. Corpus callosotomy for epilepsy: II. Neurology and neuropsychiatric outcome. Neurology. 1988;38:19–24
  56. Shin C, McNamara JO, Morgan JI, Curran T, Cohen DR. Induction of c-fos mRNA expression by afterdischarge in the hippocampus of naive and kindled rats. J. Neurochem. 1990;55:1050–1055
  57. Spencer SS, Spencer DD, Williamson PD, Sass K, Novelly RA, Mattson RH. Corpus callosotomy for epilepsy. I. Seizure effects. Neurology. 1988;38:19–24
  58. Szekely AM, Barbaccia ML, Alho H, Costa E. In primary cultures of cerebellar granule cells the activation of N-methyl-d-aspartate-sensitive glutamate receptors induces c-fos mRNA expression. Am. Soc. Exp. Ther. 1989;35:401–408
  59. Takaya M, Terry WJ, Naritoku DK. Pretreatment with vagus nerve stimulation (VNS) results in a sustained anticonvulsant effect. Epilepsia. 1994;35(S8):6
  60. Terry WJ, Naritoku DK. Patterns of fos production in the forebrain following intermittent vagus nerve stimulation. Epilepsia. 1993;34(S6):8–9
  61. Woodbury DM, Woodbury JW. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia. 1990;31(S2):S7–S19
  62. Woodbury JW, Woodbury DM. Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: Use of a cuff electrode for stimulating and recording. Pacing Clin. Electrophysiol. 1991;14:94–107
  63. Zabarra J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992;33:1005–1012
  64. Zanchetti A, Wang SC, Moruzzi G. The effects of vagal afferent stimulation on the EEG pattern of the cat. EEG Clin. Neurophysiol. 1952;5:357–361

PII: 0920-1211(95)00035-9

Epilepsy Research
Volume 22, Issue 1 , Pages 53-62 , September 1995

Article Tools